Skip to content
Menu

RBC Capital Downgrades Perspective Therapeutics to Sector Perform, Lowers Price Target to $4

Benzinga Newsdesk 3 weeks ago

Analyst RatingsNewsDowngradesPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

RBC Capital analyst Leonid Timashev downgrades Perspective Therapeutics (AMEX:CATX) from Outperform to Sector Perform and lowers the price target from $14 to $4.

RBC Capital analyst Leonid Timashev downgrades Perspective Therapeutics (AMEX:CATX) from Outperform to Sector Perform and lowers the price target from $14 to $4.

Read at benzinga.com

← All stock news